Transcription of NHSN Biovigilance Component Protocol
{{id}} {{{paragraph}}}
nhsn Biovigilance Component hemovigilance Module Surveillance Protocol Page 1 of 30 April 2018 National Healthcare Safety Network Biovigilance Component hemovigilance Module Surveillance Protocol Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention Atlanta, GA, USA nhsn Biovigilance Component hemovigilance Module Surveillance Protocol Page 2 of 30 April 2018 Version History Version Release Date Summary of Revisions March 2009 First version publicly released. June 2010 Revised background and text in main body of document. Revised case definition criterion based on WG recommendations, pilot responses, and CDC recommendations. Updated FNHTR definition to allow reaction without documented fever.
Purpose . The National Healthcare Safety Network (NHSN) Hemovigilance (HV) Module was created to implement national surveillance of transfusion-associated adverse events aimed at improving patient safety,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
REPORT OF TRANSFUSION ADVERSE REACTION, REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD, GUIDELINES FOR MANAGEMENT OF ADVERSE, Guidelines for management of adverse transfusion reactions, Reaction, REPORT, ADVERSE, Prescribing information, Clinical Transfusion Practice, Transfusion, Of transfusion, 2013 AABB Blood Survey Report, ADVERSE EVENTS MONITORING AND REPORTING GUIDELINES, HEALTH SERVICES CODE, Immune Globulin Intravenous Human